Response by Weitz and Eikelboom to Letter Regarding Article, "Urgent Need to Measure Effects of Direct Oral Anticoagulants".
نویسندگان
چکیده
Circulation. 2016;134:186–188. DOI: 10.1161/CIRCULATIONAHA.116.022307 186
منابع مشابه
Evolving Treatments for Arterial and Venous Thrombosis
Thromboembolism involving the arterial or venous circulation is the most common cause of morbidity and mortality worldwide. Anticoagulation therapy is a cornerstone of thromboembolism prevention and treatment. Vitamin K antagonists (VKAs) such as warfarin were the only orally administered anticoagulants for >60 years. Although VKAs are effective, they have numerous limitations. Thus, VKAs produ...
متن کاملA replacement for warfarin: the search continues.
Vitamin K antagonists (VKAs) such as warfarin are the only oral anticoagulants currently available for clinical use. Warfarin has numerous limitations, including slow onset and offset of action, a narrow therapeutic window, and a metabolism that is affected by diet, drugs, and genetic polymorphisms.1 Because of its unpredictable dose response, warfarin requires careful coagulation monitoring to...
متن کاملDevelopment of Direct Thrombin Inhibitors
Anticoagulants are the cornerstone of therapy for conditions associated with arterial and venous thrombosis. Direct thrombin inhibitors (DTIs) are anticoagulants that bind to thrombin and block its enzymatic activity. The bivalent parenteral DTIs hirudin and bivalirudin were based on the observation that the salivary extracts of medicinal leeches prevented blood from clotting. Key events that f...
متن کاملLetter by Zhang et al Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?".
Letter by Zhang et al Regarding Article, “Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?” To the Editor: We read with great interest the recent article by Fauchier et al, in which the authors observed a positive net clinical benefit of oral anticoagulation usage for preventing stroke and other thromboembolic events in atrial fibrill...
متن کاملFactors XI and XII as Targets for New Anticoagulants
Compared with vitamin K antagonists, the direct oral anticoagulants (DOACs) are simpler to administer and are associated with less intracranial bleeding. Nonetheless, even with the DOACs, bleeding still occurs and many patients with atrial fibrillation fail to receive anticoagulant thromboprophylaxis because of the fear of bleeding. Therefore, there is an urgent need for safer anticoagulants. R...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Circulation
دوره 134 21 شماره
صفحات -
تاریخ انتشار 2016